FS Development
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FS Development and buy or sell other stocks, ETFs, and their options commission-free!About FSDC
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
CEOJohn D. Quisel, PhD
CEOJohn D. Quisel, PhD
Employees84
Employees84
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2017
Founded2017
Employees84
Employees84
FSDC Key Statistics
Market cap47.26M
Market cap47.26M
Price-Earnings ratio-17.33
Price-Earnings ratio-17.33
Dividend yield—
Dividend yield—
Average volume402.06K
Average volume402.06K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$99.50
52 Week high$99.50
52 Week low$30.82
52 Week low$30.82
Stock Snapshot
FS Development(FSDC) stock is priced at $1.35, giving the company a market capitalization of 47.26M. It carries a P/E multiple of -17.33.
On 2025-12-11, FS Development(FSDC) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for FS Development(FSDC) stock has reached 0, versus its average volume of 402.06K.
Over the past 52 weeks, FS Development(FSDC) stock has traded between a high of $99.50 and a low of $30.82.
Over the past 52 weeks, FS Development(FSDC) stock has traded between a high of $99.50 and a low of $30.82.
People also own
Based on the portfolios of people who own FSDC. This list is generated using Robinhood data, and it’s not a recommendation.